1. A transfer-RNA-derived small RNA regulates ribosome biogenesis
- Author
-
Biswajoy Roy-Chaudhuri, Qiangfeng Cliff Zhang, Wei Wei, Mei-Sze Chua, Hak Kyun Kim, Mark A. Kay, Shengchun Wang, Jianpeng Xu, Yue Zhang, Feijie Zhang, Pan Li, Samuel So, Gabriele Fuchs, Kirk Chu, Hyesuk Park, and Peter Sarnow
- Subjects
0301 basic medicine ,Small RNA ,Multidisciplinary ,Chemistry ,5.8S ribosomal RNA ,RNA ,Translation (biology) ,Ribosomal RNA ,Cell biology ,03 medical and health sciences ,030104 developmental biology ,Ribosomal protein ,Gene expression ,Transfer RNA - Abstract
Transfer-RNA-derived small RNAs (tsRNAs; also called tRNA-derived fragments) are an abundant class of small non-coding RNAs whose biological roles are not well understood. Here we show that inhibition of a specific tsRNA, LeuCAG3′tsRNA, induces apoptosis in rapidly dividing cells in vitro and in a patient-derived orthotopic hepatocellular carcinoma model in mice. This tsRNA binds at least two ribosomal protein mRNAs (RPS28 and RPS15) to enhance their translation. A decrease in translation of RPS28 mRNA blocks pre-18S ribosomal RNA processing, resulting in a reduction in the number of 40S ribosomal subunits. These data establish a post-transcriptional mechanism that can fine-tune gene expression during different physiological states and provide a potential new target for treating cancer. A 22-nucleotide fragment of a transfer RNA regulates translation by binding to the mRNA of a ribosomal protein and increasing its expression, and downregulation of the fragment in patient-derived liver tumour cells reduces tumour growth in mice. The functional roles of small RNA fragments derived from tRNAs are not well known, but evidence is growing that some play a part in various cellular processes. Mark Kay and colleagues show that a 22-nucleotide fragment from the 3′ end of leucine tRNA can regulate translation. The fragment binds to the mRNA of a ribosomal protein to upregulate its expression. When this interaction is suppressed in human cells in culture, cell death occurs. Decreasing the levels of the tRNA fragment with an antisense oligonucleotide can slow the growth of liver tumours in mice. Technologies aimed at reducing expression of this tRNA fragment might have utility in treating cancer.
- Published
- 2017
- Full Text
- View/download PDF